Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase

Toxicology in Vitro

Volumn 24, Issue 5, 2010, Pages 1356-1362

  You, Bo Ra ^a   Park, Woo Hyun ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Gallic acid; GSH; Lung cancer cell; NAC; ROS

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; BUTHIONINE SULFOXIMINE; GALLIC ACID; GLUTATHIONE; HYDROXYL RADICAL; LIPOCORTIN 5; OXYGEN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL DEATH; CELL GROWTH; CELL LOSS; CONTROLLED STUDY; CYTOTOXICITY; DRUG CYTOTOXICITY; DRUG INDUCED CANCER; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; LUNG ADENOCARCINOMA; LUNG CANCER; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN DEPLETION; RELATIVE BIOLOGIC EFFECTIVENESS;

ACETYLCYSTEINE; ANTINEOPLASTIC AGENTS; ASCORBIC ACID; BUTHIONINE SULFOXIMINE; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; GALLIC ACID; GLUTATHIONE; HUMANS; LUNG NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 77953613901     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.04.009     Document Type: Article

References (38)

1. Agarwal C., Tyagi A., Agarwal R. Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells. Mol. Cancer Ther. 2006, 5:3294-3302.
2. Bailey H.H. L-S,R-buthionine sulfoximine: historical development and clinical issues. Chem. Biol. Interact. 1998, 111-112:239-254.
3. Baran C.P., Zeigler M.M., Tridandapani S., Marsh C.B. The role of ROS and RNS in regulating life and death of blood monocytes. Curr. Pharm. Des. 2004, 10:855-866.
4. Chen H.M., Wu Y.C., Chia Y.C., Chang F.R., Hsu H.K., Hsieh Y.C., Chen C.C., Yuan S.S. Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells. Cancer Lett. 2009, 286:161-171.
5. Faried A., Kurnia D., Faried L.S., Usman N., Miyazaki T., Kato H., Kuwano H. Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. Int. J. Oncol. 2007, 30:605-613.
6. Han Y.H., Kim S.H., Kim S.Z., Park W.H. Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion. Int. J. Oncol. 2008, 33:1099-1105.
7. Han Y.H., Kim S.Z., Kim S.H., Park W.H. Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Am. J. Physiol. Renal. Physiol. 2007, 293:F511-F520.
8. Han Y.H., Moon H.J., You B.R., Kim S.Z., Kim S.H., Park W.H. The effects of N-acetyl cysteine on the MG132 proteasome inhibitor-treated lung cancer cells in relation to cell growth, reactive oxygen species and glutathione. Int. J. Mol. Med. 2010, 25:657-662.
9. Han Y.H., Moon H.J., You B.R., Park W.H. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione. Food Chem. Toxicol.: Int. J. Publ. British Indus. Biol. Res. Associat. 2010, 48:271-276.
10. Han Y.H., Park W.H. Growth inhibition in antimycin A treated-lung cancer Calu-6 cells via inducing a G1 phase arrest and apoptosis. Lung Cancer 2009, 65:150-160.
11. Han Y.H., Park W.H. Propyl gallate inhibits the growth of HeLa cells via regulating intracellular GSH level. Food Chem. Toxicol.: Int. J. Publ. British Indus. Biol. Res. Associat. 2009, 47:2531-2538.
12. Han Y.H., Park W.H. The effects of MAPK inhibitors on a proteasome inhibitor, MG132-induced HeLa cell death in relation to reactive oxygen species and glutathione. Toxicol. Lett. 2010, 192:134-140.
13. Inoue M., Sakaguchi N., Isuzugawa K., Tani H., Ogihara Y. Role of reactive oxygen species in gallic acid-induced apoptosis. Biol. Pharm. Bull. 2000, 23:1153-1157.
14. Inoue M., Suzuki R., Koide T., Sakaguchi N., Ogihara Y., Yabu Y. Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochem. Biophys. Res. Commun. 1994, 204:898-904.
15. Inoue M., Suzuki R., Sakaguchi N., Li Z., Takeda T., Ogihara Y., Jiang B.Y., Chen Y. Selective induction of cell death in cancer cells by gallic acid. Biol. Pharm. Bull. 1995, 18:1526-1530.
16. Isuzugawa K., Inoue M., Ogihara Y. Catalase contents in cells determine sensitivity to the apoptosis inducer gallic acid. Biol. Pharm. Bull. 2001, 24:1022-1026.
17. Kang M.S., Oh J.S., Kang I.C., Hong S.J., Choi C.H. Inhibitory effect of methyl gallate and gallic acid on oral bacteria. J. Microbiol. 2008, 46:744-750.
18. Kaur M., Velmurugan B., Rajamanickam S., Agarwal R., Agarwal C. Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice. Pharm. Res. 2009, 26:2133-2140.
19. Kawada M., Ohno Y., Ri Y., Ikoma T., Yuugetu H., Asai T., Watanabe M., Yasuda N., Akao S., Takemura G., Minatoguchi S., Gotoh K., Fujiwara H., Fukuda K. Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice. Anticancer Drugs 2001, 12:847-852.
20. Kim S.H., Jun C.D., Suk K., Choi B.J., Lim H., Park S., Lee S.H., Shin H.Y., Kim D.K., Shin T.Y. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol. Sci. 2006, 91:123-131.
21. Kratz J.M., Andrighetti-Frohner C.R., Leal P.C., Nunes R.J., Yunes R.A., Trybala E., Bergstrom T., Barardi C.R., Simoes C.M. Evaluation of anti-HSV-2 activity of gallic acid and pentyl gallate. Biol. Pharm. Bull. 2008, 31:903-907.
22. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81:230S-242S.
23. Niemetz R., Gross G.G. Enzymology of gallotannin and ellagitannin biosynthesis. Phytochemistry 2005, 66:2001-2011.
24. Ohno Y., Fukuda K., Takemura G., Toyota M., Watanabe M., Yasuda N., Xinbin Q., Maruyama R., Akao S., Gotou K., Fujiwara T., Fujiwara H. Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 1999, 10:845-851.
25. Petty R.D., Nicolson M.C., Kerr K.M., Collie-Duguid E., Murray G.I. Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin. Cancer Res. 2004, 10:3237-3248.
26. Poot M., Teubert H., Rabinovitch P.S., Kavanagh T.J. De novo synthesis of glutathione is required for both entry into and progression through the cell cycle. J. Cell. Physiol. 1995, 163:555-560.
27. Sakagami H., Satoh K. Prooxidant action of two antioxidants: ascorbic acid and gallic acid. Anticancer Res. 1997, 17:221-224.
28. Schnelldorfer T., Gansauge S., Gansauge F., Schlosser S., Beger H.G., Nussler A.K. Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 2000, 89:1440-1447.
29. Serrano A., Palacios C., Roy G., Cespon C., Villar M.L., Nocito M., Gonzalez-Porque P. Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Arch. Biochem. Biophys. 1998, 350:49-54.
30. Shahrzad S., Aoyagi K., Winter A., Koyama A., Bitsch I. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J. Nutr. 2001, 131:1207-1210.
31. Simon H.U., Haj-Yehia A., Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000, 5:415-418.
32. Strlic M., Radovic T., Kolar J., Pihlar B. Anti- and prooxidative properties of gallic acid in fenton-type systems. J. Agric. Food Chem. 2002, 50:6313-6317.
33. Veluri R., Singh R.P., Liu Z., Thompson J.A., Agarwal R., Agarwal C. Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells. Carcinogenesis 2006, 27:1445-1453.
34. Wallach-Dayan S.B., Izbicki G., Cohen P.Y., Gerstl-Golan R., Fine A., Breuer R. Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L790-L796.
35. Wilcox C.S. Reactive oxygen species: roles in blood pressure and kidney function. Curr. Hypertens Rep. 2002, 4:160-166.
36. You, B.R., Moon, H.J., Han, Y.H., Park, W.H., 2010. Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis. Food Chem. Toxicol.: Int. J. Publ. British Indus. Biol. Res. Associat.
37. Zelko I.N., Mariani T.J., Folz R.J. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med. 2002, 33:337-349.
38. Zorov D.B., Juhaszova M., Sollott S.J. Mitochondrial ROS-induced ROS release: an update and review. Biochim. Biophys. Acta 2006, 1757:509-517.